12:00 AM
 | 
Dec 05, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Modiodal modafinil regulatory update

Mitsubishi and Alfresa said Japan approved Modiodal modafinil for excessive diurnal sleepiness accompanied by obstructive sleep apnea (OSA) syndrome in patients under treatment for airway obstruction by continuous positive airway...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >